85992-005 ONIADBA Hair Growth Serum Roll-on

Manufacturer
Shenzhen Boyimei Technology Co., Ltd.
Effective date
2026-07-20
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
daily-update
Hydrated at
2026-07-22 05:10:05

Label at a glance#

ProductONIADBA Hair Growth Serum Roll-on
Active ingredientROSEMARY
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Rosemary 3%

OTC - PURPOSE SECTION

Hair Growth

INDICATIONS & USAGE SECTION


1.Boosts hair growth naturally, strengthens hair & promotes healthy hair growth.
2.Extends hair growth cycle,protects hair from damage and boosts resilience.
3.Balances scalp oil & tissue.

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION


Your hair loss is sudden or patchy.
Your hair loss is associated with childbirth.
You do not know the reason for your hair loss.
You are under 18 years of age. Do not use on babies and children.
Your scalp is red, inflamed, infected, irritated, or painful.
You use other medicines on the scalp.

OTC - WHEN USING SECTION


Avoid contact with the eyes. In case of accidental contact, rinse your eyes with large amounts of cool tap water.
Some people have experienced changes in hair color and/or texture.
lt takes time to regrow hair. Results may occur at 3 months with twice a day usage. For some men, you may need to use this product for at least 6 months before you see results. The amount of hair regrowth is different for each person.
Avoid contact with eyes. In case of accidental contact, rinse your eyes with a large amount of cool tap water.

OTC - STOP USE SECTION


Chest pain, rapid heartbeat, faintness, or dizziness occurs.
Sudden, unexplained weight gain occurs.
If unwanted facial hair growth occurs .
If you do not see hair regrowth in 6 months.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


Keep out of reach of children.lf swallowed, get medical help or contact a Poison Control Center
(1-800-222-1222)right away.

DOSAGE & ADMINISTRATION SECTION


Roll this non-messy formulamultiple times on the affectedarea of your scalp until youfinish 1ml in the scale given onthe side on the label If it comesin contact with your hands, wash after use

INACTIVE INGREDIENT SECTION

Aqua, Butanediol,Biotin, Rosemary, Redensyl, Aminexil,Anagain, Arborvitae Leaf Extract, Vigna Radiata, Red Clover,Sorbic Acid Potassium Salt, Finasteride,Sodium Hyaluronate,Pantothenic Acid,Copper Peptide

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label1label1label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
928d249c-35c3-4d88-a9ef-cf2f2e31b96fProduct name120220706
d00474ae-23eb-a8eb-bf56-520e590cc6dbProduct name220170406
0f90664c-9d0e-f046-dc6a-73563cd8347eProduct name220170405

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85992-00585992-005-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12026-04-13full-release2026-06-01 01:53:33

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ONIADBA Hair Growth Serum Roll-on3% ROSEMARYShenzhen Boyimei Technology Co., Ltd.4f5266ff-f412-ea0e-e063-6394a90a357a2026-07-20WarningsExact identifier
ndc (package): 85992-005-01
ndc (product): 85992-005
ndc11 (package): 85992000501
spl id: 57056ea5-0fa2-3330-e063-6394a90acb81
spl set id: 4f5266ff-f412-ea0e-e063-6394a90a357a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.